The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?

Viral vector CDMO services for cell and gene therapies

End-to-end viral vector manufacturing services—from process development to GMP production for clinical and commercial programs.

Thermo Fisher Scientific’s viral vector CDMO services support the development and manufacturing of viral vectors for advanced therapeutics, including cell and gene therapies.

Our integrated capabilities span process development, analytical testing, and GMP manufacturing to help advance programs from early development through commercialization.

With more than 20 years of experience in the viral vector services space, we partner with biotech and pharmaceutical companies to deliver scalable, compliant manufacturing solutions.

What the viral vector services brochure covers

This brochure provides detailed insight into our experience, capacity, and capabilities for viral vectors, including:

  • Comprehensive overview of Thermo Fisher’s viral vector capabilities
  • Flexible equipment options to support a variety of manufacturing needs
  • Analytical development to support robust manufacturing processes
  • Phased approach and collaborative readiness assessment for tech transfer
  • Global network of sites with 85,000+ sq. ft. of manufacturing space
  • Regulatory expertise across the cell and gene therapy product lifecycle

Download the brochure to see how our viral vector offerings help deliver breakthrough medicines to patients.

Leading Viral Vector CDMO Services for Cell and Gene Therapies